Navigation Links
American Society for Microbiology honors Thomas E. Wellems
Date:9/14/2007

Washington, DCSeptember 13, 2007 The 2007 American Society for Microbiology (ASM) sanofi-aventis U.S. Award will be presented to Thomas E. Wellems, M.D., Ph.D., Chief, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland. Supported by an unrestricted grant from sanofi-aventis U.S., this award honors outstanding accomplishment in antimicrobial chemotherapy.

Dr. Wellems has had an outstanding career in infectious disease, most of which he has devoted to the study of malaria and its treatment. Resistance to chloroquine, a popular malaria vaccine that was very successful in the 1950s, has dramatically increased death rates from malaria in Africa and Asia. Dr. Wellems was able to identify the chloroquine transporter and develop a diagnostic test, which has made serious impacts on malaria treatment. Among other important findings, Wellems has published in more than 100 papers. He has received many honors, including the Bailey K. Ashford Medal for distinguished work in tropical medicine and the LePrince A. Medal for outstanding work in the field of malariology, both from the American Society of Tropical Medicine and Hygiene; the Lincei Golgi Medal, Academia Nazionale dei Lincei, Rome; and the Howard Taylor Rickets Awards Lecture, The University of Chicago. He is also a Fellow of the American Academy of Microbiology.

Dr. Wellems received two B.S. degrees in Physics and Chemistry from New Mexico Institute of Mining and Technology, and an M.D. and Ph.D. in Biophysics in the University of Chicagos Medical Scientist Training Program. He completed his residency at the Hospital of the University of Pennsylvania, and his fellowship training at the Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases.


'/>"/>

Contact: Peggy McNult
pmcnult@asmusa.org
202-942-9225
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
2. Health costs soar as 60 million Americans classed as obese
3. Discovery of an American salamander where it shouldnt be: Korea
4. DNA traces evolution of extinct sabertooths and the American cheetah-like cat
5. North & South American researchers find architectural abnormalities in T. cruzi ribosome
6. T-rays: New imaging technology spotlighted by American Chemical Society
7. New peptide antibiotic isolated from American oyster
8. Computers to save unique type of American red squirrel
9. Alcoholism, smoking and genetics among Plains American Indians
10. Gene variation increases SIDS risk in African Americans
11. Americans support free access to research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... VILNIUS, Lithuania , March 21, 2017 /PRNewswire/ ... identification and object recognition technologies, today announced the ... development kit (SDK), which provides improved facial recognition ... safety cameras on a single computer. The new ... algorithms to improve accuracy, and it utilizes a ...
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation ... on the desired increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, ... of therapeutic antibodies. , To meet this demand, the team at SCIEX ...
(Date:3/22/2017)... USA, and CARDIFF, UK (PRWEB) , ... March 21, 2017 , ... ... blood flow and tissue oxygenation, is being explored as a way to track the ... spectroscopy study on tonic pain activation by cold pressor test ,” published today in ...
(Date:3/22/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced Alexey ... present at the 5th Annual Cancer BioPartnering & ... to present to and meet with thought leaders ... companies as well as institutional investors. This event ...
(Date:3/20/2017)... ... March 20, 2017 , ... Avexegen Therapeutics Inc., an ... it has entered into an exclusive global license agreement with Children’s Hospital Los ... Enterocolitis (rare orphan disease) as well as Crohn’s Disease and Ulcerative Colitis. ...
Breaking Biology Technology: